ISCAR
Dead / Abandoned — Abandoned — no statement of use filed (as of 02 Sept 2024)
What this means for you
This application is over — abandoned 02 Sept 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90590454
- Mark type
- Stylized text
- Filed
- 19 Mar 2021
- Published for opposition
- 07 Dec 2021
- Abandoned
- 02 Sept 2024
- Attorney of record
- Jonathan M. Gelchinsky
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of autoimmune, immune mediated, and inflammatory diseases and disorders, nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment and prevention of autoimmune, immune mediated, and inflammatory diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Therapeutic pharmaceutical for the treatment of autoimmune, immune mediated, and inflammatory diseases and disorders, nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment and prevention of autoimmune, immune mediated, and inflammatory diseases and disorders
Owner
- ORNA THERAPEUTICS, INC., Watertown, MA, US
- ORNA THERAPEUTICS, INC., Cambridge, MA, US
Prosecution history
- 02 Sept 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Sept 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 20 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jan 2024 — SOU EXTENSION 4 GRANTED
- 18 Jan 2024 — SOU EXTENSION 4 FILED
- 18 Jan 2024 — SOU TEAS EXTENSION RECEIVED
- 30 Nov 2023 — ASSIGNED TO EXAMINER
- 28 Jul 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jul 2023 — SOU EXTENSION 3 GRANTED
- 26 Jul 2023 — SOU EXTENSION 3 FILED
- 26 Jul 2023 — SOU TEAS EXTENSION RECEIVED
- 31 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Mar 2023 — SOU EXTENSION 2 GRANTED
- 01 Feb 2023 — SOU EXTENSION 2 FILED
- 30 Mar 2023 — NOTICE OF REVIVAL - E-MAILED